Phase 3,Randomized Evaluate the Efficacy Safety of the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis(NASH)

August 02, 2018
https://clinicaltrials.gov/ct2/show/NCT03028740
Gastroenterology Hepatology
Principal Investigator: Kimberly A Brown, MD

NASH,Non Alcoholic Steatohepatitis, Liver Fibrosis

Open